Medical treatment of osteoporosis in men
Eiken, P.A.; Vestergaard, P.
Ugeskrift for Laeger 177(36)
2015
ISSN/ISBN: 1603-6824 PMID: 26324291 Document Number: 685616
One in five men over the age of 50 years will suffer an osteoporotic fracture during their lifetime, and men who sustain fractures have an increased mortality risk compared to women. Three bisphosphonates (alendronate, risedronate and zolendronic acid), denosumab, strontium ranelate and teriparatide are currently approved in Denmark for the treatment of osteoporosis in men. This review summarizes the available therapeutic options.